methotrexate
not tagged
['lymphoma', 'dlbcl', 'lymsm']
congress #eha2023 | seung-ah yahng, catholic university of korea, presents ph iii trial results showing no difference between intrathecal mtx &amp; high-dose iv mtx for prophylaxis of cns relapse in high-risk dlbcl pts. both routes were tolerable.
#lymphoma #lymsm 
A global education platform providing clinical updates on a range of lymphoma subtypes and chronic lymphocytic leukemia (#CLL) #lymsm